Your browser doesn't support javascript.
loading
A TRICk to Improve the Effectiveness of RIC: Role of Limb Temperature in Enhancing the Effectiveness of Remote Ischemic Conditioning.
Penna, Claudia; Sorge, Matteo; Tullio, Francesca; Comità, Stefano; Femminò, Saveria; Brancaccio, Mara; Pagliaro, Pasquale.
Afiliação
  • Penna C; Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
  • Sorge M; Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.
  • Tullio F; Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
  • Comità S; Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
  • Femminò S; Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Brancaccio M; Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.
  • Pagliaro P; Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.
Biology (Basel) ; 11(1)2022 Jan 17.
Article em En | MEDLINE | ID: mdl-35053144
ABSTRACT

BACKGROUND:

Treatment of myocardial ischemia/reperfusion (IR) injury is still an unmet clinical need. A large variability of remote ischemic conditioning (RIC) protection has been reported; however, no studies have considered the temperature of the ischemic limb. We analyzed the effects of temperature on RIC protection.

METHODS:

Left hind-limbs of anesthetized male mice were immersed in warm (40 °C, warm-RIC) or cold (20 °C, cold-RIC) water and subjected to a RIC protocol (4 × 5 min limb ischemia/reperfusion). In the control groups (warm-CTR or cold-CTR), the limbs underwent thermic conditions only. Isolated hearts underwent 30 min ischemia and 60 min reperfusion. A PI3K-inhibitor, LY294002 (5 µM), was infused in warm-RIC hearts before the IR protocol (warm-RIC LY). Infarct size was evaluated by nitro blue tetrazolium staining and expressed as the percent of risk area.

RESULTS:

While cold-RIC did not reduce the infarct size compared to cold-CTR (51 ± 1.62% vs. 54 ± 1.07% of risk area, p =NS), warm-RIC (44 ± 1.13%) significantly reduced the infarct size with respect to either cold-RIC (p <0.001) or warm-CTR (58 ± 1.41%, p <0.0001). LY294002 infusion revealed the PI3K/Akt involvement in the warm-RIC protection. Infarct size reduction was abrogated by LY294002 pretreatment (warm-RIC 44 ± 1.13% vs. warm-CTR 58 ± 1.41% p <0.0001; vs. warm-RIC LY 54 ± 1.69% p =0.0002).

CONCLUSION:

our study shows a remarkable difference between warm-RIC and cold-RIC in terms of infarct size reduction, supporting a pivotal role for limb temperature in RIC-induced cardioprotection.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article